Medtronic, Inc. Loses Heart Valve Patent Fight in Germany

Published: Jul 12, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A German court ruled against Medtronic Inc in the latest round of its patent fight with Edwards Lifesciences on Friday, judging the U.S. medical device maker's heart valve technology infringes a patent owned by Edwards. Medtronic said in a statement early on Friday that it "respectfully disagrees" with the Mannheim court's decision and intends to appeal the verdict. Medtronic's CoreValve system is an artificial heart valve that can be implanted without resorting to open heart surgery. In November, the U.S. Court of Appeals for the Federal Circuit said it was upholding a decision by a federal court in Delaware that Medtronic's device infringed a patent owned by Edwards. The court awarded $74 million in lost profits and royalties.

Help employers find you! Check out all the jobs and post your resume.

Back to news